Mark L. Lupher Jr., Director at Adverum Biotechnologies, Inc. (ADVM), bought 130,000 shares at $1.35 ($176K) on 2024-02-07, disclosed to the SEC on 2024-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.